Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

TARS holding history

Tarsus Pharmaceuticals, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TARS overviewAll 13F holders of TARSFull Q2 2026 holdings

Shares (Q2 2026)
785,808
Value
$49.5M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TARS by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026785,808$49.5M<0.1%+43,311+5.8%AddedHolders
Q1 2026742,497$52.1M<0.1%−269,860−26.7%ReducedHolders
Q4 20251,012,357$82.9M<0.1%+75,351+8.0%AddedHolders
Q3 2025937,006$55.7M<0.1%+8,505+0.9%AddedHolders
Q2 2025928,501$37.6M<0.1%+101,978+12.3%AddedHolders
Q1 2025826,523$42.5M<0.1%−105,592−11.3%ReducedHolders
Q4 2024932,115$51.6M<0.1%+250,018+36.7%AddedHolders
Q3 2024682,097$22.4M<0.1%+290,534+74.2%AddedHolders
Q2 2024391,563$10.6M<0.1%+167,994+75.1%AddedHolders
Q1 2024223,569$8.13M<0.1%+125,696+128.4%AddedHolders
Q4 202397,873$1.98M<0.1%+97,873NewHolders
Q3 20230$00.0%−41,769−100.0%Sold outHolders
Q2 202341,769$754.8K<0.1%−19,409−31.7%ReducedHolders
Q1 202361,178$769.0K<0.1%+4,444+7.8%AddedHolders
Q4 202256,734$831.7K<0.1%+16,071+39.5%AddedHolders
Q3 202240,663$696.0K<0.1%−1,954−4.6%ReducedHolders
Q2 202242,617$622.0K<0.1%+14,635+52.3%AddedHolders
Q1 202227,982$471.0K<0.1%+4,078+17.1%AddedHolders
Q4 202123,904$538.0K<0.1%−4,710−16.5%ReducedHolders
Q3 202128,614$616.0K<0.1%−1,814−6.0%ReducedHolders
Q2 202130,428$882.0K<0.1%+1,169+4.0%AddedHolders
Q1 202129,259$943.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.